Exponent (EXPO) Q4 Earnings: What To Expect

via StockStory

EXPO Cover Image

Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday after market hours. Here’s what you need to know.

Exponent beat analysts’ revenue expectations by 4% last quarter, reporting revenues of $137.1 million, up 9.6% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

Is Exponent a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Exponent’s revenue to grow 3.5% year on year to $128.1 million, slowing from the 8.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.47 per share.

Exponent Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Exponent has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Exponent’s peers in the professional services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Concentrix delivered year-on-year revenue growth of 4.3%, beating analysts’ expectations by 0.7%, and Broadridge reported revenues up 7.8%, topping estimates by 6.5%. Concentrix traded up 2.3% following the results.

Read our full analysis of Concentrix’s results here and Broadridge’s results here.

Investors in the professional services segment have had fairly steady hands going into earnings, with share prices down 1.4% on average over the last month. Exponent is down 5.2% during the same time and is heading into earnings with an average analyst price target of $90.33 (compared to the current share price of $69.90).

P.S. STOP buying the AI stocks everyone's talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.